PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells

Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes

(2020) Gianluca Testa et al.   Scientific Reports

GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors

(2020) Yujie Fu et al.   Scientific Reports

PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis

(2020) Chengcheng Hao et al.   Frontiers in Oncology

Spatial and temporal heterogeneity of PD-L1 expression and tumor mutational burden in gastroesophageal adenocarcinoma at baseline diagnosis and after chemotherapy

(2020) Katherine I Zhou et al.   CLINICAL CANCER RESEARCH

Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer

(2020) Shani Ben Dori et al.   LUNG CANCER

Modeling How Heterogeneity in Cell Cycle Length Affects Cancer Cell Growth Dynamics in Response to Treatment

(2020) Eleftheria Tzamali et al.   Frontiers in Oncology

Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma

(2020) Francesca Ida Montalto et al.   Cells

The Prognostic and Therapeutic Value of PD-L1 in Glioma

(2019) Ruo Qiao Chen et al.   Frontiers in Pharmacology

IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment

(2019) Deborah Rotoli et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Effects of Long-Term Citrate Treatment in the PC3 Prostate Cancer Cell Line

(2019) Carmen Caiazza et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Author Correction: Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance

(2019) Jinfang Zhang et al.   NATURE

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response

(2019) Alexander Haragan et al.   LUNG CANCER

Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasis

(2019) Simona Romano et al.   SEMINARS IN CANCER BIOLOGY

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor

(2018) Zhi-liang Wang et al.   OncoImmunology

A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma

(2017) Paolo D'Arrigo et al.   Oncotarget

Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma

(2017) Song Xue et al.   Oncotarget

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

(2017) Angel Garcia-Diaz et al.   Cell Reports

Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

(2016) Y. Lou et al.   CLINICAL CANCER RESEARCH

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

(2016) David A. Reardon et al.   NEURO-ONCOLOGY

Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy

(2016) T. M. Johanns et al.   Cancer Discovery

PD-L1 expression and prognostic impact in glioblastoma

(2015) Edjah K. Nduom et al.   NEURO-ONCOLOGY

FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma

(2015) Simona Romano et al.   NUCLEIC ACIDS RESEARCH

Immunomodulatory pathways regulate expression of a spliced FKBP51 isoform in lymphocytes of melanoma patients

(2015) Simona Romano et al.   Pigment Cell & Melanoma Research

FK506 Binding Protein Mediates Glioma Cell Growth and Sensitivity to Rapamycin Treatment by Regulating NF-κB Signaling Pathway

(2015) Wei Jiang et al.   NEOPLASIA

The Emerging Role of Large Immunophilin FK506 Binding Protein 51 in Cancer

(2011) S. Romano et al.   CURRENT MEDICINAL CHEMISTRY

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols